Distribution of unexpected antibodies identified at domestic and international centers N (%)
| Antibody types | Domestics | Internationals | |||||
|---|---|---|---|---|---|---|---|
| P hospital 2002∼2007 | P hospital 2008∼2015 [7] | S hospital 2012∼2015 | D hospital 2016∼2017 [8] | Saudi population 2019∼2020 [9] | North India 2015∼2017 [10] | ||
| Rh | |||||||
| Anti-E | 196 (22.45) | 107 (17.12) | 704 (18.69) | 19 (22.09) | 20 (18.69) | 10 (4.03) | |
| Anti-e | 1 (0.11) | 6 (0.96) | |||||
| Anti-C | 8 (0.92) | 3 (0.48) | 1 (0.03) | 2 (2.33) | 10 (9.35) | 8 (3.23) | |
| Anti-c | 1 (0.11) | 2 (0.32) | 2 (2.33) | 1 (0.93) | 6 (2.42) | ||
| Anti-D | 17 (1.95) | 17 (2.72) | 5 (5.81) | 31 (28.97) | 18 (7.26) | ||
| Anti-E+c | 60 (6.87) | 56 (8.96) | 265 (7.04) | 4 (4.65) | |||
| Anti-E+C | 1 (0.93) | ||||||
| Anti-D+C | 7 (6.54) | ||||||
| Anti-C+e | 36 (4.12) | 11 (1.76) | 4 (4.65) | ||||
| Anti-Cw | 9 (3.63) | ||||||
| Lewis | |||||||
| Anti-Le (a) | 82 (9.39) | 27 (4.32) | 349 (9.27) | 3 (3.49) | 6 (5.61) | 23 (9.27) | |
| Anti-Le (b) | 11 (1.26) | 10 (1.60) | 3 (3.49) | 8 (3.23) | |||
| Anti-Le (a)+Le (b) | 1 (1.16) | ||||||
| Kidd | |||||||
| Anti-Jk (a) | 7 (0.80) | 11 (1.76) | 1 (1.16) | 12 (11.21) | 10 (4.03) | ||
| Anti-Jk (b) | 2 (0.23) | 2 (0.32) | 3 (3.49) | 11 (4.44) | |||
| Duffy | |||||||
| Anti-Fy (b) | 12 (1.37) | 7 (1.12) | 3 (3.49) | 10 (4.03) | |||
| Anti-Fy (a) | 1 (0.16) | 1 (1.16) | 13 (5.24) | ||||
| Xg | |||||||
| Anti-Xg | 11 (1.26) | 2 (0.32) | 7 (0.19) | ||||
| MNSs | |||||||
| Anti-M | 18 (2.06) | 203 (5.39) | 2 (2.33) | 2 (1.87) | 51 (20.56) | ||
| Anti-N | 1 (0.11) | 28 (11.29) | |||||
| Anti-S | 5 (0.57) | 1 (0.03) | 1 (1.16) | 5 (4.67) | 8 (3.23) | ||
| Mixed antibodies | |||||||
| Anti-M+E | 1 (0.93) | ||||||
| Anti-S+E | 1 (0.93) | ||||||
| Anti-K+Fy (a) | 2 (1.87) | ||||||
| Anti-D+K | 2 (0.81) | ||||||
| Anti-D+E | 5 (0.57) | 1 (0.40) | |||||
| Other | 10 (1.15) | 30 (0.80) | |||||
| Rh+Kidd | |||||||
| Anti-E/-c/-Jk (b) | 1 (0.16) | 1 (1.16) | |||||
| Anti-Di (a) | 14 (0.37) | ||||||
| Anti-C+Le (a) | 1 (0.16) | ||||||
| Anti-Le (a)+P1 | 1 (0.03) | ||||||
| Anti-E+Di (a) | 4 (0.46) | 1 (0.16) | |||||
| Anti-e+Di (a) | 1 (0.16) | ||||||
| Anti-M+Fy (b) | 1 (0.16) | ||||||
| Anti-E+c+S | 1 (0.16) | ||||||
| Anti-E+JK (a) | 2 (0.23) | ||||||
| Anti-E+JK (b) | 1 (0.03) | ||||||
| Anti-E+c+Di (a) | 2 (0.23) | ||||||
| Anti-Di (a) | 60 (6.87) | 28 (4.48) | |||||
| Anti-P1 | 3 (0.34) | 7 (1.12) | 117 (3.11) | 10 (4.03) | |||
| Anti-K | 2 (0.32) | 8 (7.48) | 10 (4.03) | ||||
| Anti-Kp (b) | 7 (2.82) | ||||||
| Anti-Lu (b) | 5 (2.02) | ||||||
| Unidentified | 230 (26.35) | 195 (31.20) | 2010 (53.37) | 26 (30.23) | - | - | |
| Autoantibody | 89 (10.19) | 125 (20.00) | 63 (1.67) | 5 (5.81) | - | - | |
| Total | 873 (100.00) | 625 (100.00) | 3,766 (100.00) | 86 (100.00) | 107 (100.00) | 248 (100.00) | |
